olimestra 10 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - olmesartan medoxomil - 58 - hypotensiva
astexana 25 mg
vipharm s.a., poľsko - exemestán - 44 - cytostatica
wilate 500
octapharma (ip) sprl, belgicko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
wilate 1000
octapharma (ip) sprl, belgicko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
co-olimestra 20 mg/12,5 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - olmesartan medoxomil a diuretiká - 58 - hypotensiva
co-olimestra 40 mg/25 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - olmesartan medoxomil a diuretiká - 58 - hypotensiva
co-olimestra 40 mg/12,5 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - olmesartan medoxomil a diuretiká - 58 - hypotensiva
diclofenac dr. müller pharma 100 mg čapíky
dr. müller pharma s.r.o., Česká republika - diklofenak - 29 - antirheumatica, antiphlogistica, antiuratica
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
amorolfín belupo 50 mg/ml liečivý lak na nechty
belupo, s.r.o., slovensko - amorolfín - 26 - antimycotica (lokÁlne a celkovÉ)